A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer

Clinical trial NCT00626548 · TERMINATED

Trial details

NCT number: NCT00626548
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2008-01-01
Primary completion: 2011-01-01
Enrollment: 2577

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.